Minor
Enicepatide (CT-388) · Overweight or Obese With Type 2 Diabetes Mellitus
Trial completed
Carmot Therapeutics, Inc.Phase 2 NCT06628362 Registry history of NCT06628362 on ClinicalTrials.gov (opens the registry)
Data updated daily from ClinicalTrials.gov.